Q1 FY27 — 22 Jul 2026
MPS Q1 FY27
MPS Limited delivered a strong Q1 FY27, marked by robust revenue growth of 20.4% and a significant 53.0% increase in EBITDA, with margins expanding to 34.3%. The company achieved a 'Rule of 50' score of 54%, reflecting effective operating leverage and a strategic shift towards outcomes-based revenue. Key segments like Education and Corporate Learning showed strong performance and margin improvement, while the Unbound Medicine acquisition is integrating well and contributing to predictable revenue streams. Management reaffirmed its FY27 EBITDA target of over INR 300 crores, expressing high conv
Read the full call






